Monsanto Company (MON.N)
80.52USD
18 Dec 2009
$-0.22 (-0.27%)
$80.74
$81.13
$81.31
$79.96
2,302,600
4,286,587
$93.35
$65.60
MON.N
About
Overall
| Beta: | 0.73 |
| Market Cap (Mil.): | $44,007.74 |
| Shares Outstanding (Mil.): | 545.05 |
| Annual Dividend: | 1.06 |
| Yield (%): | 1.31 |
Financials
| MON.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 21.42 | 44.05 | 7.90 |
| EPS (TTM): | 5.21 | -- | -- |
| ROI: | 15.34 | 15.23 | 0.02 |
| ROE: | 21.60 | 20.74 | 0.01 |
USDA seeks comment on genetically modified alfalfa
WASHINGTON, Dec 14 (Reuters) - The U.S. Agriculture Department on Monday said it determined there would be no significant environmental harm to deregulating genetically modified alfalfa, but said it will open its preliminary finding to public comment before issuing a final decision.
Brazil approves its second gene-modified soy
SAO PAULO, Dec 11 (Reuters) - Brazilian authorities have approved the use of a new genetically-modified soy seed which was developed jointly by BASF and state agricultural researchers in the world's No. 2 soy exporter.
Monsanto shares set to rise in long term: report
NEW YORK (Reuters) - Monsanto Co's shares are set to rise in the long-term although the leading chemicals and biotech seed developer currently faces obstacles including tough competition from China in the herbicide business, Barron's said.
Monsanto shares set to rise in long term-Barron's
NEW YORK, Nov 29 (Reuters) - Monsanto Co's shares are set to rise in the long-term although the leading chemicals and biotech seed developer currently faces obstacles including tough competition from China in the herbicide business, Barron's said.
CORRECTED - (OFFICIAL)-UPDATE 1-Brazil does not clear use of Bayer GMO soy
(Officially corrects agency's spokeswoman's statement that CTNBio cleared Bayer GMO soy for commercial use)
Biotech crops cause big jump in pesticide use: report
KANSAS CITY (Reuters) - The rapid adoption by U.S. farmers of genetically engineered corn, soybeans and cotton has promoted increased use of pesticides, an epidemic of herbicide-resistant weeds and more chemical residues in foods, according to a report issued Tuesday by health and environmental protection groups.
Biotech crops cause big jump in pesticide use-report
KANSAS CITY, Nov 17 (Reuters) - The rapid adoption by U.S. farmers of genetically engineered corn, soybeans and cotton has promoted increased use of pesticides, an epidemic of herbicide-resistant weeds and more chemical residues in foods, according to a report issued Tuesday by health and environmental protection groups.
FACTBOX-Agri industry invests to raise farm output
Nov 13 (Reuters) - Major food and agriculture companies are investing in sustainable farm development around the world as part of long-term strategies to secure reliable supplies, cut costs and boost positions on new markets.
EU meeting on Syngenta GM maize ends in deadlock
BRUSSELS, Nov 13 (Reuters) - EU ambassadors failed to approve a genetically-modified maize made by Swiss firm Syngenta in talks on Friday, meaning the application will now be sent to EU ministers for a decision next week.
CORRECTED - TIMELINE: History of Monsanto Co.
(In 1982 entry, corrects reference to Monsanto and Times Beach controversy)
Competitors
| Price | Change | |
|---|---|---|
| Bayer AG (BAYGn.DE) | €54.21 | -0.16 |
| Bayer AG (BAYE.F) | -- | -- |
| The Dow Chemical Company (DOW.N) | $26.22 | -0.26 |
| E.I. du Pont de Nemours & Company (DD.N) | $31.87 | -0.14 |
| BASF SE (BASF.DE) | €42.99 | -0.19 |
| Syngenta AG (SYNN.VX) | CHF288.10 | +3.00 |
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
